Heejin Bae
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Heejin Bae has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Yong Eun Chung
Department of Radiology, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Republic of Korea.
3 shared publications - Jaeseung Shin
Department of Radiology, Samsung Medical Center, 81 Irwon-ro, Irwon-dong - Gangnam-gu, Seoul, 06351, Republic of Korea, 82 10-8714-7650
2 shared publications - Joon Seok Lim
Department of Radiology, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea
2 shared publications - June Park
Department of Radiology, Yonsei University College of Medicine, Seoul, Korea
2 shared publications - Kyunghwa Han
Department of Radiology, Center for Clinical Imaging Data Science, Research Institute of Radiological Sciences, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea
2 shared publications - Byung Soh Min
Department of Surgery, Yonsei University College of Medicine, Seoul, Korea
1 shared publication
Latest Publications
- Open Access
- 1 January 2024
- Published by XMLink in Investigative Magnetic Resonance Imaging
- Vol. 28 (1) , 27-35
Comparison of Volumetric Measurement Method With Region of Interest Drawing Method for Liver Fat Quantification
Lee H, et al. Investig Magn Reson Imaging. 2024 Mar;28(1):27-35. https://doi.org/10.13104/imri.2023.0020
- 1 January 2024
- Published by XMLink in Investigative Magnetic Resonance Imaging
- Vol. 28 (1) , 27-35
Open AccessComparison of Volumetric Measurement Method With Region of Interest Drawing Method for Liver Fat Quantification
Lee H, et al. Investig Magn Reson Imaging. 2024 Mar;28(1):27-35. https://doi.org/10.13104/imri.2023.0020
- Open Access
- 1 January 2024
- Published by XMLink in Korean Journal of Radiology
- Vol. 25 (3) , 257-266
Safety of Administering Intravenous CT Contrast Agents Repeatedly or Using Both CT and MRI Contrast Agents on the Same Day: An Animal Study
Bae H, et al. Korean J Radiol. 2024 Mar;25(3):257-266. https://doi.org/10.3348/kjr.2023.0712
- 1 January 2024
- Published by XMLink in Korean Journal of Radiology
- Vol. 25 (3) , 257-266
Open AccessSafety of Administering Intravenous CT Contrast Agents Repeatedly or Using Both CT and MRI Contrast Agents on the Same Day: An Animal Study
Bae H, et al. Korean J Radiol. 2024 Mar;25(3):257-266. https://doi.org/10.3348/kjr.2023.0712
- 23 November 2023
- Published by Springer Nature in European Radiology
- Vol. 34 (6) , 3686-3698
Pretreatment MRI-detected extramural venous invasion as a prognostic and predictive biomarker for neoadjuvant chemoradiotherapy in non-metastatic rectal cancer: a propensity score matched analysis
Objectives This study evaluated pretreatment magnetic resonance imaging (MRI)–detected extramural venous invasion (pmrEMVI) as a predictor of survival after neoadjuvant chemoradiotherapy (nCRT) in patients with locally advanced rectal cancer (LARC). Materials and methods Medical records of 1184 patients with rectal adenocarcinoma who underwent TME between January 2011 and December 2016 were reviewed. MRI data were collected from a computerized radiologic database. Cox proportional hazards analysis was used to assess local, systemic recurrence, and disease-free survival risk based on pretreatment MRI-assessed tumor characteristics. After propensity score matching (PSM) for pretreatment MRI features, nCRT therapeutic outcomes according to pmrEMVI status were evaluated. Cox proportional hazards analysis was used to identify risk factors for early recurrence in patients receiving nCRT. Results Median follow-up was 62.8 months. Among all patients, the presence of pmrEMVI was significantly associated with worse disease-free survival (DFS; HR 1.827, 95% CI 1.285–2.597, p = 0.001) and systemic recurrence (HR 2.080, 95% CI 1.400–3.090, p < 0.001) but not local recurrence. Among patients with pmrEMVI, nCRT provided no benefit for oncological outcomes before or after PSM. Furthermore, pmrEMVI( +) was the only factor associated with early recurrence on multivariate analysis in patients receiving nCRT. Conclusions pmrEMVI is a poor prognostic factor for DFS and SR in patients with non-metastatic rectal cancer and also serves as a predictive biomarker of poor DFS and SR following nCRT in LARC. Therefore, for patients who are positive for pmrEMVI, consideration of alternative treatment strategies may be warranted. Clinical relevance statement This study demonstrated the usefulness of pmrEMVI as a predictive biomarker for nCRT, which may assist in initial treatment decision-making in patients with non-metastatic rectal cancer. Key Points • Pretreatment MRI-detected extramural venous invasion (pmrEMVI) was significantly associated with worse disease-free survival and systemic recurrence in patients with non-metastatic rectal cancer. • pmrEMVI is a predictive biomarker of poor DFS following nCRT in patients with LARC. • The presence of pmrEMVI was the only factor associated with early recurrence on multivariate analysis in patients receiving nCRT.
- 23 November 2023
- Published by Springer Nature in European Radiology
- Vol. 34 (6) , 3686-3698
Pretreatment MRI-detected extramural venous invasion as a prognostic and predictive biomarker for neoadjuvant chemoradiotherapy in non-metastatic rectal cancer: a propensity score matched analysis
Objectives This study evaluated pretreatment magnetic resonance imaging (MRI)–detected extramural venous invasion (pmrEMVI) as a predictor of survival after neoadjuvant chemoradiotherapy (nCRT) in patients with locally advanced rectal cancer (LARC). Materials and methods Medical records of 1184 patients with rectal adenocarcinoma who underwent TME between January 2011 and December 2016 were reviewed. MRI data were collected from a computerized radiologic database. Cox proportional hazards analysis was used to assess local, systemic recurrence, and disease-free survival risk based on pretreatment MRI-assessed tumor characteristics. After propensity score matching (PSM) for pretreatment MRI features, nCRT therapeutic outcomes according to pmrEMVI status were evaluated. Cox proportional hazards analysis was used to identify risk factors for early recurrence in patients receiving nCRT. Results Median follow-up was 62.8 months. Among all patients, the presence of pmrEMVI was significantly associated with worse disease-free survival (DFS; HR 1.827, 95% CI 1.285–2.597, p = 0.001) and systemic recurrence (HR 2.080, 95% CI 1.400–3.090, p < 0.001) but not local recurrence. Among patients with pmrEMVI, nCRT provided no benefit for oncological outcomes before or after PSM. Furthermore, pmrEMVI( +) was the only factor associated with early recurrence on multivariate analysis in patients receiving nCRT. Conclusions pmrEMVI is a poor prognostic factor for DFS and SR in patients with non-metastatic rectal cancer and also serves as a predictive biomarker of poor DFS and SR following nCRT in LARC. Therefore, for patients who are positive for pmrEMVI, consideration of alternative treatment strategies may be warranted. Clinical relevance statement This study demonstrated the usefulness of pmrEMVI as a predictive biomarker for nCRT, which may assist in initial treatment decision-making in patients with non-metastatic rectal cancer. Key Points • Pretreatment MRI-detected extramural venous invasion (pmrEMVI) was significantly associated with worse disease-free survival and systemic recurrence in patients with non-metastatic rectal cancer. • pmrEMVI is a predictive biomarker of poor DFS following nCRT in patients with LARC. • The presence of pmrEMVI was the only factor associated with early recurrence on multivariate analysis in patients receiving nCRT.
- Open Access
- 1 January 2022
- Published by XMLink in Korean Journal of Radiology
- Vol. 23 (4) , 402-412
Image Quality and Lesion Detectability of Lower-Dose Abdominopelvic CT Obtained Using Deep Learning Image Reconstruction
Park J, et al. Korean J Radiol. 2022 Jan;23:e19. https://doi.org/10.3348/kjr.2021.0683
- 1 January 2022
- Published by XMLink in Korean Journal of Radiology
- Vol. 23 (4) , 402-412
Open AccessImage Quality and Lesion Detectability of Lower-Dose Abdominopelvic CT Obtained Using Deep Learning Image Reconstruction
Park J, et al. Korean J Radiol. 2022 Jan;23:e19. https://doi.org/10.3348/kjr.2021.0683
- Open Access
- 1 January 2021
- Published by XMLink in Yonsei Medical Journal
- Vol. 62 (8) , 758-766
Effectiveness of Hepatocellular Carcinoma Surveillance and an Optimal Surveillance Interval: Nationwide Cohort of Korea
Bae H, et al. Yonsei Med J. 2021 Aug;62(8):758-766. https://doi.org/10.3349/ymj.2021.62.8.758
- 1 January 2021
- Published by XMLink in Yonsei Medical Journal
- Vol. 62 (8) , 758-766
Open AccessEffectiveness of Hepatocellular Carcinoma Surveillance and an Optimal Surveillance Interval: Nationwide Cohort of Korea
Bae H, et al. Yonsei Med J. 2021 Aug;62(8):758-766. https://doi.org/10.3349/ymj.2021.62.8.758
- Open Access
- 1 January 2021
- Published by XMLink in Korean Journal of Radiology
- Vol. 22 (6) , 912-921
Diagnostic Performance of Deep Learning-Based Lesion Detection Algorithm in CT for Detecting Hepatic Metastasis from Colorectal Cancer
Kim K, et al. Korean J Radiol. 2021 Jun;22(6):912-921. https://doi.org/10.3348/kjr.2020.0447
- 1 January 2021
- Published by XMLink in Korean Journal of Radiology
- Vol. 22 (6) , 912-921
Open AccessDiagnostic Performance of Deep Learning-Based Lesion Detection Algorithm in CT for Detecting Hepatic Metastasis from Colorectal Cancer
Kim K, et al. Korean J Radiol. 2021 Jun;22(6):912-921. https://doi.org/10.3348/kjr.2020.0447
- Open Access
- 1 April 2019
- Published by Korean Society of Ultrasound in Medicine in Ultrasonography
- Vol. 38 (2) , 143-148
Development of a multi-channel NIRS-USG hybrid imaging system for detecting prostate cancer and improving the accuracy of imaging-based diagnosis: a phantom study
This study aimed to develop a multi-channel near-infrared spectroscopy (NIRS) and ultrasonography (USG) fusion imaging system for imaging prostate cancer and to verify its diagnostic capability by applying the hybrid imaging system to a prostate cancer phantom. A multi-channel NIRS system using the near-infrared 785-nm wavelength with 12 channels and four detectors was developed. After arranging the optical fibers around a USG transducer, we performed NIRS imaging and grayscale USG imaging simultaneously. Fusion imaging was obtained by processing incoming signals and the spatial reconstruction of NIRS, which corresponded with grayscale USG acquired at the same time. The NIRS-USG hybrid system was applied to a silicone-based optical phantom of the prostate gland containing prostate cancer to verify its diagnostic capability qualitatively. The NIRS-USG hybrid imaging system for prostate cancer imaging simultaneously provided anatomical and optical information with 2-dimensional registration. The hybrid imaging system showed more NIR attenuation over the prostate cancer model than over the model of normal prostate tissue. Its diagnostic capability to discriminate a focal area mimicking the optical properties of prostate cancer from the surrounding background mimicking the optical properties of normal prostate tissue was verified by applying the hybrid system to a silicone-based optical phantom of prostate cancer. This study successfully demonstrated that the NIRS-USG hybrid system may serve as a new imaging method for improving the diagnostic accuracy of prostate cancer, with potential utility for future clinical applications.
- 1 April 2019
- Published by Korean Society of Ultrasound in Medicine in Ultrasonography
- Vol. 38 (2) , 143-148
Open AccessDevelopment of a multi-channel NIRS-USG hybrid imaging system for detecting prostate cancer and improving the accuracy of imaging-based diagnosis: a phantom study
This study aimed to develop a multi-channel near-infrared spectroscopy (NIRS) and ultrasonography (USG) fusion imaging system for imaging prostate cancer and to verify its diagnostic capability by applying the hybrid imaging system to a prostate cancer phantom. A multi-channel NIRS system using the near-infrared 785-nm wavelength with 12 channels and four detectors was developed. After arranging the optical fibers around a USG transducer, we performed NIRS imaging and grayscale USG imaging simultaneously. Fusion imaging was obtained by processing incoming signals and the spatial reconstruction of NIRS, which corresponded with grayscale USG acquired at the same time. The NIRS-USG hybrid system was applied to a silicone-based optical phantom of the prostate gland containing prostate cancer to verify its diagnostic capability qualitatively. The NIRS-USG hybrid imaging system for prostate cancer imaging simultaneously provided anatomical and optical information with 2-dimensional registration. The hybrid imaging system showed more NIR attenuation over the prostate cancer model than over the model of normal prostate tissue. Its diagnostic capability to discriminate a focal area mimicking the optical properties of prostate cancer from the surrounding background mimicking the optical properties of normal prostate tissue was verified by applying the hybrid system to a silicone-based optical phantom of prostate cancer. This study successfully demonstrated that the NIRS-USG hybrid system may serve as a new imaging method for improving the diagnostic accuracy of prostate cancer, with potential utility for future clinical applications.